Follow
Prosenjit Kundu
Prosenjit Kundu
Biostatistician, Pfizer Inc.
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Individual and community-level risk for COVID-19 mortality in the United States
J Jin, N Agarwala, P Kundu, B Harvey, Y Zhang, E Wallace, N Chatterjee
Nature medicine 27 (2), 264-269, 2021
792021
Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality
A Meisner, P Kundu, YD Zhang, LV Lan, S Kim, D Ghandwani, ...
The American Journal of Human Genetics 107 (3), 418-431, 2020
562020
Generalized meta-analysis for multiple regression models across studies with disparate covariate information
P Kundu, R Tang, N Chatterjee
Biometrika 106 (3), 567-585, 2019
532019
Quantifying the predictive performance of objectively measured physical activity on mortality in the UK Biobank
A Leroux, S Xu, P Kundu, J Muschelli, E Smirnova, N Chatterjee, ...
The Journals of Gerontology: Series A 76 (8), 1486-1494, 2021
412021
Isolated diastolic hypertension in the UK Biobank: comparison of ACC/AHA and ESC/NICE guideline definitions
BP McGrath, P Kundu, N Daya, J Coresh, E Selvin, JW McEvoy, ...
Hypertension 76 (3), 699-706, 2020
362020
Case-only analysis of gene-environment interactions using polygenic risk scores
A Meisner, P Kundu, N Chatterjee
American journal of epidemiology 188 (11), 2013-2020, 2019
172019
Smoking modifies pancreatic cancer risk loci on 2q21. 3
E Mocci, P Kundu, W Wheeler, AA Arslan, LE Beane-Freeman, PM Bracci, ...
Cancer research 81 (11), 3134-3143, 2021
132021
Transparency, reproducibility, and validation of COVID-19 projection models
J Jin, N Agarwala, P Kundu, R Zhao, N Chatterjee
Johns Hopkins Bloomberg School of Public Health Expert Insights, 2020
62020
Pathogen exposure misclassification can bias association signals in GWAS of infectious diseases when using population-based common control subjects
D Duchen, C Vergara, CL Thio, P Kundu, N Chatterjee, DL Thomas, ...
The American Journal of Human Genetics 110 (2), 336-348, 2023
32023
Estimating Burden of Mortality due to Excess Body Mass Index in the US Adult Population by Combining Evidence from a Mendelian Randomization Study and National Health Surveys
P Kundu, S Burgess, N Chatterjee
medRxiv, 2023
12023
Genome-wide interaction scan identifies gene by smoking interaction at 2q21. 3 for pancreatic cancer risk
P Kundu, E Mocci, W Wheeler, LT Amundadottir, D Li, EJ Jacobs, ...
Cancer Research 80 (16_Supplement), 1213-1213, 2020
12020
Heterogeneous Transfer Learning for Building High-Dimensional Generalized Linear Models with Disparate Datasets
R Zhao, P Kundu, A Saha, N Chatterjee
arXiv preprint arXiv:2312.12786, 2023
2023
Logistic regression analysis of two-phase studies using generalized method of moments
P Kundu, N Chatterjee
Biometrics 79 (1), 241-252, 2023
2023
Provider and Patient Characteristics of Medicare Beneficiaries Who Are High-Risk for COVID-19 Mortality
J Ballreich, J Jin, P Kundu, N Chatterjee
Journal of general internal medicine 36 (7), 2189-2190, 2021
2021
Estimating the size of high-risk populations for COVID-19 death in the Americas
P Kundu, T Alapati, N Agarwala, R Caixeta, D Ondarsuhu, SG Saiso, ...
https://iris.paho.org/handle/10665.2/53269, 2021
2021
STATISTICAL METHODS FOR INTEGRATING DISPARATE DATA SOURCES
P Kundu
Johns Hopkins University, 2020
2020
Analysis of Two-Phase Studies using Generalized Method of Moments
P Kundu, N Chatterjee
arXiv preprint arXiv:1910.11991, 2019
2019
Testing Equality of Curves after Covariate Adjustment
P Pal Choudhury, P Kundu, QL Xue, R Westbrook, CM Crainiceanu
bioRxiv, 228148, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–18